Severe Immune Thrombocytopenia Induced by a Single Dose of Nivolumab in a Patient with Advanced Non-Small Cell Lung Cancer
Abstract
Share and Cite
Khorasanchi, A.; Keresztes, R. Severe Immune Thrombocytopenia Induced by a Single Dose of Nivolumab in a Patient with Advanced Non-Small Cell Lung Cancer. Clin. Pract. 2020, 10, 1249. https://doi.org/10.4081/cp.2020.1249
Khorasanchi A, Keresztes R. Severe Immune Thrombocytopenia Induced by a Single Dose of Nivolumab in a Patient with Advanced Non-Small Cell Lung Cancer. Clinics and Practice. 2020; 10(2):1249. https://doi.org/10.4081/cp.2020.1249
Chicago/Turabian StyleKhorasanchi, Adam, and Roger Keresztes. 2020. "Severe Immune Thrombocytopenia Induced by a Single Dose of Nivolumab in a Patient with Advanced Non-Small Cell Lung Cancer" Clinics and Practice 10, no. 2: 1249. https://doi.org/10.4081/cp.2020.1249
APA StyleKhorasanchi, A., & Keresztes, R. (2020). Severe Immune Thrombocytopenia Induced by a Single Dose of Nivolumab in a Patient with Advanced Non-Small Cell Lung Cancer. Clinics and Practice, 10(2), 1249. https://doi.org/10.4081/cp.2020.1249